Hi ,
Instos have their own reasons for selling.Its not always a reflection on the company involved.
It's only a few months until we get the trial results.
They are already booked in at the conferences and correct me if Iam wrong but I can't recall dud results getting a podium.
Lepu are right Cavatak is the leading oncolyic candidate whether the share price is 60c or $1.30?.
Aloha.
Ann: Ceasing to be a substantial holder, page-14
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)